DENTSPLY SIRONA Inc.
General ticker "XRAY" information:
- Sector: Health Care
- Industry: Health Care Equipment & Supplies
- Capitalization: $3.2B (TTM average)
DENTSPLY SIRONA Inc. follows the US Stock Market performance with the rate: 4.2%.
Estimated limits based on current volatility of 1.4%: low 11.19$, high 11.55$
Factors to consider:
- Company pays dividends (irregularly): last record date 2025-09-26, amount 0.16$ (Y1.42%)
- Total employees count: 14000 (-6.7%) as of 2024
- Top business risk factors: Cybersecurity threats, Product development risks, Reimbursement risks, Goodwill impairment, Reputation and brand risks
- Current price 11.7% below estimated low
- Earnings for 9 months up through Q3 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2024-12-31 to 2026-12-31
- 2024-12-31 to 2025-12-31 estimated range: [12.77$, 23.38$]
- 2025-12-31 to 2026-12-31 estimated range: [12.75$, 22.93$]
Financial Metrics affecting the XRAY estimates:
- Positive: with PPE of 11.3 at the end of fiscal year the price was neutral
- Negative: negative Operating income
- Negative: negative Net income
- Positive: 18.93 < Shareholder equity ratio, % of 33.76 <= 41.86
- Positive: 6.82 < Operating cash flow per share per price, % of 12.05
- Negative: 0.79 < Interest expense per share per price, % of 1.80
- Positive: 0 < Industry operating cash flow per share per price (median), % of 0.78
- Positive: -8.75 < Industry operating profit margin (median), % of -7.19
- Positive: -14.38 < Investing cash flow per share per price, % of -5.15
- Negative: Industry inventory ratio change (median), % of 1.55 > 0.28
Short-term XRAY quotes
Long-term XRAY plot with estimates
Financial data
| YTD | 2022-12-31 | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Operating Revenue | $3,922.00MM | $3,965.00MM | $3,793.00MM |
| Operating Expenses | $4,859.00MM | $4,050.00MM | $4,672.00MM |
| Operating Income | $-937.00MM | $-85.00MM | $-879.00MM |
| Non-Operating Income | $-118.00MM | $-90.00MM | $-57.00MM |
| Interest Expense | $65.00MM | $81.00MM | $69.00MM |
| R&D Expense | $174.00MM | $184.00MM | $165.00MM |
| Income(Loss) | $-1,055.00MM | $-175.00MM | $-936.00MM |
| Taxes | $-105.00MM | $-43.00MM | $-26.00MM |
| Profit(Loss)* | $-950.00MM | $-132.00MM | $-910.00MM |
| Stockholders Equity | $3,811.00MM | $3,293.00MM | $1,942.00MM |
| Inventory | $627.00MM | $624.00MM | $564.00MM |
| Assets | $7,643.00MM | $7,370.00MM | $5,753.00MM |
| Operating Cash Flow | $517.00MM | $377.00MM | $461.00MM |
| Capital expenditure | $149.00MM | $149.00MM | $180.00MM |
| Investing Cash Flow | $-138.00MM | $-89.00MM | $-197.00MM |
| Financing Cash Flow | $-329.00MM | $-307.00MM | $-302.00MM |
| Earnings Per Share** | $-4.41 | $-0.62 | $-4.48 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.